Cynomolgus PCSK9 Protein (Cynomolgus PCSK9, His Tag) Gln 31 - Gln 692 (Accession # G7NVZ1) was produced in human 293 cells (HEK293) at ACROBiosystems.
Cynomolgus PCSK9, His Tag is fused with a polyhistidine tag at the C-terminus, and has a calculated MW of 73.2 kDa. The predicted N-terminus is Gln 31. The reducing (R) protein migrates as 20 kDa and 65 kDa in SDS-PAGE .
Less than 1.0 EU per μg of the Cynomolgus PCSK9, His Tag by the LAL method.
>95% as determined by SDS-PAGE.
Lyophilized from 0.22 μm filtered solution in PBS, pH7.4. Normally Mannitol or Trehalose are added as protectants before lyophilization.
Contact us for customized product form or formulation.
See Certificate of Analysis for reconstitution instructions and specific concentrations.
Avoid repeated freeze-thaw cycles.
No activity loss was observed after storage at:
In lyophilized state for 1 year (4°C); After reconstitution under sterile conditions for 3 months (-70°C).
Proprotein convertase subtilisin/kexin type 9 (PCSK9) is also known as NARC1 (neural apoptosis regulated convertase), is a newly identified subtilase belonging to the peptidase S8 subfamily. Mouse PCSK9 is synthesized as a soluble zymogen, and undergoes autocatalytic intramolecular processing in the endoplasmic reticulum, resulting in the cleavage of its propeptide that remains associated with the secreted active enzyme with a broad alkaline pH optimum. This protein plays a major regulatory role in cholesterol homeostasis. PCSK9 binds to the epidermal growth factor-like repeat A (EGF-A) domain of the low-density lipoprotein receptor (LDLR), inducing LDLR degradation. PCSK9 may also have a role in the differentiation of cortical neurons. Mutations in this gene have been associated with a rare form of autosomal dominant familial hypercholesterolemia (HCHOLA3).
Please contact us via TechSupport@acrobiosystems.com if you have any question on this product.